Livros e Capítulos de Livros - LIM/17

URI Permanente para esta coleção

A coleção de Livros e Capítulos de Livros reúne capítulos e resumos de obras produzidas por autores do sistema FMUSP-HC que inclui a Faculdade de Medicina da Universidade de São Paulo (FMUSP), o Hospital das Clínicas da FMUSP e demais institutos associados.

Navegar

Submissões Recentes

Agora exibindo 1 - 20 de 143
  • bookPart 0 Citação(ões) na Scopus
    Vogt-Koyanagi-Harada disease
    (2011) CARVALHO, J. F. de; SOUZA, A. W. de; YAMAMOTO, J. H.; APPENZELLER, S.
    The term panuveitis is reserved for diseases that involve all segments of the uveal tract, including the retina and vitreous body. It is usually associated with severe sight-threatening inflammatory response. The common causes of panuveitis in our population are tuberculosis, syphilis, Vogt-Koyanagi-Harada disease, sympathetic ophthalmia, Behçet’s disease and sarcoidosis. Vogt-Koyanagi-Harada disease (VKH) is a multisystem autoimmune disorder affecting pigmented tissues such as the eye, auditory, integumentary and central nervous systems. Patients are typically females between 20 to 50 years old with no previous history of penetrating ocular trauma. Despite the increasing reports published about the clinical features of VKHdisease in various ethnic populations, the etiology of VKH disease is still not completely known. Clinical, laboratorial, experimental data corroborate to the autoimmune nature of VKH disease in a genetically susceptible individual. A stepwise approach is essential while evaluating these patients to be able to identify and treat the disease timely and adequately. Ancillary tests can be appropriately applied once the clinical diagnosis is made. Treatment is based on initial high-dose oral corticosteroids with a low tapering during a minimum period of 6 months. Systemic immunomodulatory agents such as cyclosporine may be used in refractory or corticosteroid non-tolerant patients. Visual prognosis is usually good under a prompt diagnosis and adequate treatment. The aim of this paper is to review the latest research results on VKH disease in order to help to understand better this potentially blinding disease and to improve treatment. © 2011 Nova Science Publishers, Inc.
  • bookPart 0 Citação(ões) na Scopus
    DO YOU HAVE TO LIE TO INDUCE PLACEBO EFFECTS?: The use of open label placebos in sport and exercise
    (2023) SAUNDERS, B.; MARTICORENA, F. M.; GUALANO, B.
    The use of deceptive placebo in practice is inherently fraught with ethical constraints and trust issues, meaning that alternative methods must be employed in practice. This has led to the development of an alternative approach through which placebo effects might be generated, namely open-label placebo (also called “honest placebo”). This method consists of openly informing the individual that they are receiving an inert intervention (i.e., a placebo). While there is a growing body of evidence demonstrating the efficacy of this method in clinical practice, data in sport and exercise remain scarce. In this chapter, we discuss the use of open-label placebo as a potential ergogenic intervention in the context of exercise and sports, we propose theoretical mechanisms through which they work, and we place an emphasis on practical applications and research gaps in this emerging area of research. © 2024 selection and editorial matter, Philip Hurst and Chris Beedie; individual chapters, the contributors.
  • bookPart
    Apresentação
    (2023) BONFá, Eloisa Silva Dutra de Oliveira
  • bookPart
    Emergências reumatológicas sistêmicas e vasculares no departamento de emergência
    (2017) PROKOPOWITSCH, Aleksander Snioka; KURUMA, Kátia Akemi Miyazato; BORBA NETO, Eduardo Ferreira
  • bookPart
    Conceitos e condutas em traumatologia ortopédica
    (2017) BRAGGIATO, Charlene da Rocha; NORDON, David Gonçalves; ESSU, Felipe Futema; RODRIGUES, José Eduardo de Castro Matheus; SENDACZ, Pedro Tossoli
  • bookPart
    Artrite séptica e osteomielite
    (2023) SHIMODA-SAKANO, Tania; BRITO, Gisele Mendes
  • bookPart
    Esclerose sistêmica
    (2023) SAMPAIO-BARROS, Percival Degrava
  • bookPart
    Tendinopatias e bursites
    (2023) PINTO, Ana Lucia de Sá; LIMA, Fernanda Rodrigues
  • bookPart
    Osteoartrite
    (2023) ROSA NETO, Nilton Salles; FULLER, Ricardo
  • bookPart
    Manejo perioperatório de drogas utilizadas nas afecções reumatológicas
    (2023) FRANCO, André Silva; PEREIRA, Rosa Maria Rodrigues
  • bookPart
    Dor em reumatologia
    (2019) FULLER, Ricardo; SHINJO, Samuel Katsuyuki; KOBAYASHI, Carolina Besser Cozac
  • bookPart
    Doenças reumatológicas
    (2023) LIMA, Lívia Maria Lindoso; DUARTE, Nilo José Coêlho; AIKAWA, Nádia Emi; CAMPOS, Lucia Maria de Arruda; DELGADO, Artur Figueiredo; SILVA, Clovis Artur Almeida da
  • bookPart 6 Citação(ões) na Scopus
    Nutrition in Combat Sports
    (2018) ARTIOLI, G. G.; SOLIS, M. Y.; TRITTO, A. C.; FRANCHINI, E.
    High-intensity intermittent efforts are applied in most combat sports. Major reasons of fatigue, tiredness, and reduced performance are caused by (1) muscle acidosis, (2) glycogen depletion in the muscle, (3) phosphocreatine depletion in the muscle, (4) dehydration, (5) elevated extracellular K+ concentration, and (6) micronutrient deficiency. The chapter highlights the importance of nutrients and nutritional strategies to minimize fatigue and maximize training adaptations in combat sports. Weight management and loss is a very vital parameter in combat athletes. This topic has been discussed. Finally this review highlighted diverse nutraceutical supplements that can be effectively used in sports performance. © 2019 Elsevier Inc. All rights reserved.
  • bookPart 1 Citação(ões) na Scopus
    Biochemistry of buffering capacity and ingestion of buffers in exercise and athletic performance
    (2020) SAUNDERS, B.; ARTIOLI, G. G.; DOLAN, E.; JONES, R. L.; MATTHEWS, J.; SALE, C.
  • bookPart 0 Citação(ões) na Scopus
    Vitamin K: Metabolism, sources and interaction with foods and oral anticoagulants
    (2012) KLACK, K.; CARVALHO, J. F.
    Vitamin K is a fat-soluble vitamin that is primarily involved in blood coagulation. Vitamin K denotes a group of the following substances: Phylloquinone (K1- predominant), Dihydrophylloquinone (dK), Menaquinone (K2) and Menadione (K3). The absorption of vitamin K is affected by several conditions, such as poor gastrointestinal absorption, biliary secretion and insufficient dietary intake. The main sources of vitamin K are vegetables and oils, and phylloquinone is the major dietary form of vitamin K. Dark green leafy vegetables, foods cooked in oil, oilseeds and fruits such as kiwis, avocados, grapes, plums and figs contain high levels of vitamin K. On the other hand, cereals, grains, breads and dairy products contain low levels of vitamin K. The daily intake of approximately 1 μg of vitamin K per kilo of body weight is considered safe, even in the case of oral anticoagulant use; a stable concentration of the vitamin helps to increase the efficacy of treatment. Warfarin is the most commonly used anticoagulant drug and is used as both prophylaxis and therapy for the treatment of thromboembolic complications. The use of warfarin is monitored by the prothrombin time, which is expressed as the international normalized ratio (INR). The aim of this monitoring is to set a therapeutic range of the INR of 2-3 in order to minimize the risk of hemorrhaging. The anticoagulation effect may be reduced by weight gain, diarrhea, vomiting, being under 40 years of age and excessive dietary intake of vitamin K. © 2012 Nova Science Publishers, Inc.
  • bookPart 0 Citação(ões) na Scopus
    Radiographic assessment of psoriatic arthritis (PsA)
    (2016) ROSA, J.; SAMPAIO-BARROS, P. D.; SORIANO, E. R.
    Radiographs are accessible, inexpensive and safe, and therefore remain the generally accepted means for imaging assessment of joint disease in PsA. Radiographs can help in making a diagnosis of PsA, are useful in differentiating PsA from other diseases, and have been used as an outcome measure in the clinical trials and observational studies in PsA. Although there are not specifi c radiographic features in PsA, there are some typical characteristics that are very useful, and should prompt the physician to think about PsA. These are discussed and described in this chapter, and include: predilection for the distal interphalangeal (DIP) joints of the hands and interphalangeal joint of the great toe, the absence of juxtaarticular osteopenia, the presence of large erosions with bony proliferation (pencil-in-cup image), the presence of osteolysis and ankylosis (sometimes in the same hand or fi nger), periostitis, and the presence of enthesal erosions and calcifi cations. We also discuss the importance of baseline radiographs in disease prognosis, and the different radiographs scoring methods that have been validated for use in PsA clinical trials and observational studies. © Springer International Publishing Switzerland 2016.
  • bookPart 0 Citação(ões) na Scopus
    Beta-alanine supplementation in sport, exercise and health
    (2019) SAUNDERS, B.; DOLAN, E.
  • bookPart 0 Citação(ões) na Scopus
    Dermatomyositis in rheumatologist's view
    (2014) SCHAINBERG, C. G.; ADEDUNTAN, R.
    Dermatomyositis (DM) is a chronic idiopathic inflammatory systemic diseasecharacterized by muscle inflammation due to perivascular involvement, usually expressedby weakness; typical cutaneous inflammation may accompany, precede or follow themuscle complaint. DM can occur at any age. In general it is believed that juveniledermatomyositis (JDM), which occurs before age 18, encompass more vasculopathy andless autoantibodies compared to the disease that affects adults. For adults, the peakincidence is close to 50 years of age, there is a female predominance and it is estimatedthat the incidence of DM is close to 9.5 cases per million people. © 2015 by Nova Science Publishers, Inc. All rights reserved.
  • bookPart 3 Citação(ões) na Scopus
    Creatine supplementation in sport, exercise and health
    (2019) RAWSON, E. S.; DOLAN, E.; SAUNDERS, B.; WILLIAMS, M. E.; GUALANO, B.